Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metformin with Abiraterone in mCRPC
NCT04926155Phase 2Unknown
- Sponsor
- Sun Yat-sen University
- Start
- Jun 2021
- Primary completion
- Apr 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of metformin in metastatic castration-resistant prostate cancer (mCRPC), sponsored by Sun Yat-sen University. Status: unknown.
02
Drugs
metformin
03
Conditions
metastatic castration-resistant prostate cancer (mCRPC)
Beyond the preview
Go deeper on NCT04926155.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04926155.